Skip to main content

Table 2 Relative expression level of Psoralen group over that Control group

From: Exosomes play an important role in the process of psoralen reverse multidrug resistance of breast cancer

Gene symbol

Control

Psoralen

log2FoldChange

P value

KRTAP2-3

473.4431128

77.96785331

−2.602239769

1.55E-31

FOSL1

11296.63679

5566.561955

−1.021034857

3.49E-26

MMP1

1170.248705

212.1662542

−2.463548055

1.18E-13

MYPN

456.4454562

187.019253

−1.287255674

1.63E-10

ENSG00000231826.1

761.8035897

366.7059488

−1.054795416

7.26E-08

ALPP

320.5900834

127.107873

−1.334676407

1.22E-07

ENSG00000237862.1

247.8975043

105.2724733

−1.235615498

1.45E-07

LRRC15

313.4134599

144.8134519

−1.113871516

3.37E-07

TMEM40

398.6759476

196.9516533

−1.017375042

5.19E-07

ALPL

205.4467798

88.21207065

−1.21971673

1.31E-06

TMEM200A

714.8598445

303.7664782

−1.234697743

3.42E-06

LCE2A

455.8712616

224.9098164

−1.019279833

8.62E-06

SIRPB1

43.66423935

9.736212337

−2.165019671

1.03E-05

SESN3

73.33189937

163.1626044

1.153797628

1.94E-05

PEAR1

195.9475924

80.66338615

−1.280481972

2.38E-05

HSD17B6

83.7271271

31.44521183

−1.412854769

3.95E-05

ENSG00000261159.1

17.47612762

1.611337899

−3.439054581

6.33E-05

INHBA

92.57825197

34.35526917

−1.430141936

6.82E-05

ARNT2

115.3737968

50.98582145

−1.17814759

8.87E-05

IGFN1

87.83302938

31.6306287

−1.473441332

1.02E-04

RXFP4

0

10.4296342

Inf

1.26E-04

  1. The table displays the results of the RNA-Seq data comparison before and after psoralen treatment. It holds the description, log2 fold change (FC) of the differentially expressed genes. Positive log2 fold changes indicate higher gene expression after psoralen treatment, while negative log2 fold changes indicate lower gene expression after psoralen treatment